By utilizing immunohistochemistry (IHC), studies were able to compare ER protein expression with clinicopathological characteristics in tumor tissue and illustrated differential relations to the prognosis of disease based on the localization of cells and cancer type [48]. The gene discussed is ESR1; the disease is cancer.